Related references
Note: Only part of the references are listed.Understanding the variability of the S1′ pocket to improve matrix metalloproteinase inhibitor selectivity profiles
Aleix Gimeno et al.
DRUG DISCOVERY TODAY (2020)
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Subha Mondal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
MMP24 as a Target of YAP Is a Potential Prognostic Factor in Cancer Patients
Wataru Sugimoto et al.
BIOENGINEERING-BASEL (2020)
Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and-9 activity in primary endometriotic stromal cells in vitro
Eleftherios P. Samartzis et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2019)
Biological effects of aromatic bis[aminomethylidenebis(phosphonic)] acids in osteoclast precursors in vitro
Anna Nasulewicz-Goldeman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Synthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acids
Sanchita Dutta et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Piezo1 mediates angiogenesis through activation of MT1-MMP signaling
Hojin Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Gelatinase inhibitors: a patent review (2011-2017)
Xun Li
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
MMP-12, a Promising Therapeutic Target for Neurological Diseases
Bharath Chelluboina et al.
MOLECULAR NEUROBIOLOGY (2018)
Matrix metalloproteinases in emphysema
Sina A. Gharib et al.
MATRIX BIOLOGY (2018)
Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents
Sk. Abdul Amin et al.
PHARMACOLOGICAL RESEARCH (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview
Nilanjan Adhikari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
Robert H. Scannevin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Interleukin-18, matrix metalloproteinase-22 and-29 are independent risk factors of human coronary heart disease
Dong-Yi Jin et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2017)
Detection distance calculation model of flying target and atmospheric influence analysis
Hanshan Li
OPTIK (2017)
Heart failure and role of circulating MMP-2 and MMP-9
Jana Radosinska et al.
PANMINERVA MEDICA (2017)
Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays
Nilanjan Adhikari et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models
Caterina Camodeca et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Clinical and prognostic role of matrix metalloproteinase-2,-9 and their inhibitors in breast cancer and liver diseases: A review
A. Daniele et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Agata Jablonska-Trypuc et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease
Osman Beton et al.
BIOMEDICAL REPORTS (2016)
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity
Elisa Nuti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Inhibition of MMP-13 prevents diet-induced obesity in mice and suppresses adipogenesis in 3T3-L1 preadipocytes
Chia-Li M. Shih et al.
MOLECULAR BIOLOGY REPORTS (2015)
Design of dual MMP-2/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity
Amit K. Halder et al.
RSC ADVANCES (2015)
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Jillian Cathcart et al.
GENES & DISEASES (2015)
Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases
Jacek Kurzepa et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
Duane Moogk et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
Chung-Han Hsin et al.
PLOS ONE (2014)
Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression
Aifen Lin et al.
HUMAN IMMUNOLOGY (2013)
Targeting Angiogenesis for Treatment of Human Cancer
R. R. Somani et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Crystallization of bi-functional ligand protein complexes
Claudia Antoni et al.
JOURNAL OF STRUCTURAL BIOLOGY (2013)
Matrix Metalloproteinase Inhibitor COL-3 Prevents the Development of Paclitaxel-Induced Hyperalgesia in Mice
Subramanian S. Parvathy et al.
MEDICAL PRINCIPLES AND PRACTICE (2013)
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects
Wenzhao Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
SERIES MATRIX METALLOPROTEINASES IN LUNG HEALTH AND DISEASE'' A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
R. E. Vandenbroucke et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue
C. X. Zhou et al.
AUSTRALIAN DENTAL JOURNAL (2010)
Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
Achim Krueger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition
Jennifer A. Jacobsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Serum metalloproteinase leukolysin (MMP-25/MT-6): a potential metabolic marker for atopy-associated inflammation
M. N. Blumenthal et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)
Xun Li et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)
MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer
Sonja Boyd et al.
EXPERIMENTAL DERMATOLOGY (2009)
Epidermal Growth Factor Receptor Regulates MT1-MMP and MMP-2 Synthesis in SiHa Cells via Both PI3-K/AKT and MAPK/ERK Pathways
Zongfeng Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
MMP-1 polymorphism and its relationship to pathological processes
P. A. Arakaki et al.
JOURNAL OF BIOSCIENCES (2009)
Role of lmmunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer
Martine Perigny et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli
Jose A. Rodriguez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism
Silvia D'Alessio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Jialiang Hu et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Matrix metalloproteases: Underutilized targets for drug delivery
Deepali G. Vartak et al.
JOURNAL OF DRUG TARGETING (2007)
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: A precancerous potential?
Timo Rath et al.
INFLAMMATORY BOWEL DISEASES (2006)
A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice
Dominique Ledoux et al.
ANTI-CANCER DRUGS (2006)
Gingival crevicular fluid matrix metalloproteinase-25 and-26 levels in periodontal disease
Gulnur Emingil et al.
JOURNAL OF PERIODONTOLOGY (2006)
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases
PN Lara et al.
CLINICAL CANCER RESEARCH (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)
MD Covington et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability
VS Golubkov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer
S Leppä et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery
JT Peterson
HEART FAILURE REVIEWS (2004)
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patinets with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organisation for the Research and Treatment of Cancer
FA Shepherd et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2
B Steffensen et al.
MATRIX BIOLOGY (2002)
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor
YQ Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2002)
Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds
MS Ågren et al.
EXPERIMENTAL DERMATOLOGY (2001)
The design, structure, and therapeutic application of matrix metalloproteinase inhibitors
JW Skiles et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Development of matrix metalloproteinase inhibitors in cancer therapy
M Hidalgo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Marimastat: the clinical development of a matrix metalloproteinase inhibitor
AL Thomas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Matrix metalloproteinases: Biologic activity and clinical implications
AR Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
